课题基金 / 基金详情

Analysis of multiplicity and polymorphism of drug transporters expressed in the liver.

Analysis of multiplicity and polymorphism of drug transporters expressed in the liver.
肝脏中表达的药物转运蛋白的多样性和多态性分析。
批准号:
09470501
负责人:
SUGIYAMA Yuichi
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SUGIYAMA Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Liver, along with kidney, plays an important role in the detoxification of xenobiotics. It is well established that drugs in the circulating blood are taken up into the liver via transporters on the basal membrane, and then excreted into the bile via transporters on the bile canalicular membrane. Concerning the transporters responsible for the uptake, Na^+-dependent bile acid transporter (Ntcp) and organic anion transporter 1 (oatp1) have been identified. However, no quantitative studies have been performed on the contribution of these transporters to the hepatic uptake of drugs. In the present study, we determined the contribution of each transporter in hepatic drug uptake, by comparing the ability to take up drugs into hepatocytes and into cDNA-transfected mammalian cells. The results suggested the presence of multiplicity for both Na^+-dependent and independent transport systems. Studies are under way to determine the contribution of homologous transporters (such as oatp2 and oat 3) … More . Concerning the transport across the bile canalicular membrane, the transport properties of organic anions has been identified by using the isolated bile canalicular membrane vesicles isolated from rats and humans. In addition, we have characterized the transport properties of canalicular multispecific organic anion transporter (cMOAT) using the membrane vesicles isolated from cDNA-transfected cells. Moreover, as a homologue of cMOAT, we have cloned rat and human MRP3 (multidrug resistance associated protein 3). Studies with isolated membrane vesicles from mammalian cells transfected with MRP3 cDNA, it was demonstrated that MRP3 accepts glucuronides, but not glutathione-conjugates, as good substrates. Thus, the difference in the transport characteristics was demonstrated between MRP1/2 and 3. In rats and HepG2 cells in culture, MRP3 was induced by phenobarbital, suggesting that the difference in the expression level of MRP3 may result in the interindividual difference in the ability to excrete xenobiotics and/or their conjugates into the bile in humans. Less
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木洋史: "肝臓病学の最前線" (中外医学社)山中、滝川編, (1997)
铃木宏:“肝脏疾病的最前沿”(中外医学社)山中伸弥和泷川,(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木洋史: "肝臓病学の最前線" (中外医学社)中山、滝川編, (1997)
铃木宏:《肝病前沿》(中外医学社),中山和泷川编辑,(1997 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
37
    Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
    • 批准号:
      20249008
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.7万
    • 财政年份:
      2008
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
    • 批准号:
      17209005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.78万
    • 财政年份:
      2005
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
    • 批准号:
      15390035
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      2003
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
    • 批准号:
      13557219
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2001
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    国内基金
    海外基金
    CD200-CD200R轴调控小胶质细胞Mrp8/14释放介导抑郁症发病的作用机
    多药耐药性相关蛋白MRP5的工作机理研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      刘忠民
    • 依托单位:
    基于PXR-P-gp/MRP2信号轴和PBPK模型定量研究伏立康唑对维奈克拉药动/药效的影响
    • 批准号:
      2024A02006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      刘斌
    • 依托单位:
    鹅星状病毒2型调控肾脏CXR/RXR/MRP4信号通路致雏鹅痛风的机制研究
    • 批准号:
      32372964
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      吕英军
    • 依托单位: